Magnetic Resonance Imaging–Transrectal Ultrasound Fusion‐Targeted Biopsy Improves the Diagnostic Efficacy of Overall and Clinically Significant Prostate Cancer
Compared with conventional biopsy, MRI-TRUS fusion-targeted transrectal biopsy combined with systematic biopsy could effectively detect clinically significant PCa without increasing detection of clinically insignificant PCa and adverse event rates.
Authors
- M Seki
- Nobuki Tanaka (ORCID: https://orcid.org/0009-0008-0836-3742)
- Yusuke Fukiage
- Yoshinaga Okumura (ORCID: https://orcid.org/0000-0002-2225-3418)
- Takafumi Kabuto (ORCID: https://orcid.org/0000-0003-3148-9366)
- Manami Tsutsumiuchi
- S Inamura
- Naoki Terada (ORCID: https://orcid.org/0009-0005-1082-6089)
- N. Okubo (ORCID: https://orcid.org/0009-0009-3329-4512)
- Minekatsu Taga (ORCID: https://orcid.org/0000-0002-1767-9799)
- Tadashi Kakitsuba
- Akifumi Muramoto
- Kimika Kaeriyama
- Mahiro Inamura
- Wonseok Seo
- Sahoko Shimada
Institutions
- University of Fukui (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1111/iju.70334
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00